Dermatological adverse events during hematological and oncological therapies (Bruton's tyrosine kinase inhibitors and mogamulizumab): an Italian retrospective multicenter study
Year: 2025
Type: article
Study design: Observational Study
Authors: Michela STARACE, on behalf of SIDeMaST Task Force TICURO, Stephano CEDIRIAN, Luca RAPPARINI, Corrado ZENGARINI, Laura GANDOLFI, Giulio GUALDI, Fabio LOBEFARO, Pietro SOLLENA, Pietro QUAGLINO, Simone RIBERO, Martina MERLI, Elisabetta FULGIONE, Paola VITIELLO, Giovanni PAOLINO, Franco RONGIOLETTI, Laura CALABRESE, Martina D’ONGHIA, Elisa CINOTTI, Ilaria PROIETTI, Davide FATTORE, Bianca M. PIRACCINI, Alessandro PILERI
Institutions: IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, University of Bologna, University of Chieti-Pescara, Agostino Gemelli University Polyclinic, Istituti di Ricovero e Cura a Carattere Scientifico, University of Turin, University of Campania "Luigi Vanvitelli", Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele, University of Siena, Università Cattolica del Sacro Cuore, Sapienza University of Rome, University of Naples Federico II
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4414779277